Oxford AI Predicts Heart Failure 5 Years Early
3-minute read.
Today’s biggest stories:
- OpenAI adds $100 ChatGPT pro plan
- The $12B dental playbook?
- Oxford AI predicts heart failure 5 years early
- Instagram lets you edit comments
OpenAI Adds $100 ChatGPT Pro Plan
OpenAI added a new $100/month ChatGPT Pro plan for heavy users, especially people using Codex.
OpenAI says it gives 5x more usage than Plus and, for a limited time, 10x more Codex usage than Plus.
This is not ChatGPT’s first Pro plan, OpenAI already launched a $200/month Pro plan in December 2024.
So this news is about a new lower-cost Pro tier between Plus at $20/month and Pro at $200/month.
The $12B Dental Playbook?*
Align Technology ($ALGN) IPO’d in 2001, reaching a $12B market cap by redefining the standard of care for braces.
Now, former Align and IBM execs are bringing this same playbook to wisdom teeth with TriAgenics. And this time, you can invest.
TriAgenics' patented treatment stops wisdom teeth from forming in 60-90 seconds. For dentists, that could unlock $25B in new revenue.
Invest in TriAgenics before FDA submission and commercial launch.
Oxford AI Predicts Heart Failure 5 Years Early
Oxford scientists built an AI tool that can predict heart failure risk at least five years early from heart CT scans.
It was trained and tested on data from more than 70,000 people across nine NHS trusts in England.
The tool predicted 5-year risk with 86% accuracy.
People in the highest-risk group were about 20 times more likely to develop heart failure and had about a 1 in 4 chance within five years.
Instagram Lets You Edit Comments
Instagram now lets people edit comments after posting. You can edit a comment more than once, but only within 15 minutes.
After that, it can’t be changed. Edited comments show an “Edited” label.
Before this, people had to delete and repost comments to fix typos or wording.
Instagram shows only the newest version, not the old one or any edit history. Reports also say this is for text edits, not media.
*This is a paid advertisement for TriAgenics’ Regulation CF offering. Please read the offering circular at https://invest.triagenics.com/
For general informational purposes only. Please verify the details yourself and speak with a qualified professional before making any decisions.
